Global /India /Healthcare /Drug Manufacturers - General /STAR
chevron_leftBack
Strides Pharma Science Ltd. logo

Strides Pharma Science Ltd.

STAR
NSE: STAR Delayed
1,036.80INR -1.6%
10.83 USD
As of 6 June 2026, Strides Pharma Science Ltd. has a market cap of $1.01B USD, ranking #10634 globally and #584 in India. It ranks #954 in the Healthcare sector, and #356 in the Drug Manufacturers - General industry.
Global Rank
10634
Country Rank
584
Sector Rank
954
Industry Rank
356
Key Stats
Market Cap
$1.01BUSD
97.1B INR
Enterprise Value
$1.19BUSD
113.73B INR
Revenue (TTM)
$493.53MUSD
47.26B INR
EBITDA (TTM)
$88.9MUSD
8.51B INR
Net Income (TTM)
$53.41MUSD
5.11B INR
EBITDA Margin
18%
Profit Margin
11%
PE Ratio
19.0
Forward PE
15.4
PS Ratio
2.1
PB Ratio
3.5
EV/EBITDA
12.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Badree Komandur open_in_new
Employees
3,301
Founded
1990
Website
strides.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.6% 5.7% 12% 32% 29% 59%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
STAR
Strides Pharma Science Ltd
ISIN: INE939A01011
Shares Out.:
92.173M1 Shares Float: 60.166M2
TV:
SA:
YF:
GF:
BA:
MS:
1,036.80 INR
Bombay Stock Exchange
MIC: XBOM
532531 (STAR)
Strides Pharma Science Ltd
ISIN: INE939A01011
TV:
SA:
YF:
GF:
BA:
MS:
1,053.25 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Strides Pharma Science Ltd.

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. The company was incorporated in 1990 and is based in Bengaluru, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.57B
4.27T INR
4K%
39.1
DIVISLAB
$18.12B
1.73T INR
2K%
70.0
$14.95B
1.43T INR
1K%
63.0
$11.57B
1.11T INR
1K%
19.6
MANKIND
$9.73B
931.67B INR
860%
52.2
ZYDUSLIFE
$9.57B
916.53B INR
844%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
75K%
38.1
JNJ
$547.28B
54K%
26.4
ABBV
$360.63B
35K%
97.4
$324.68B
256.25B CHF
32K%
19.9
AZN
$289.43B
215.59B GBP
28K%
27.6
NOVN
$277.35B
218.9B CHF
27K%
20.5
chevron_leftBack